UnitedHealth Stock Has Quietly Soared 80% off Its Low. Is the Worst Finally Behind It?

UnitedHealth (UNH) has surged 80% from its 2025 low of $234.60 to near $427, outpacing the S&P 500's return over the same period. The rally follows improved operational metrics and upgraded guidance from management.

The company's medical care ratio—a key profitability metric tracking claims costs against premiums—has improved, prompting management to raise 2026 earnings guidance. The moves signal operational stabilization after a turbulent start to the year.

The rebound has pushed UNH's forward P/E ratio to 23 from 13 at the trough, suggesting much of the recovery has already been priced in. An ongoing Department of Justice investigation into Medicare Advantage billing practices remains unresolved, introducing regulatory risk that could pressure shares.

The Motley Fool analyst who covered the stock recommends sidelined investors stay put, arguing the easy gains have been captured and the risk-reward balance has shifted less favorably at current valuations.